chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: M
Vaccine: SMALL
Symptoms: Complement factor normal, Condition aggravated, Cutaneous lupus erythematosus, Cytomegalovirus test positive, DNA antibody negative
Clinical narrative: This 41 year old female reported receipt of her primary DRYVAX on 25 June 2003. Three AVA vaccinations were administered on 06 Sept 2003, 22 Sept 2003, and 11 Oct 2003 with no remembered adverse events to either vaccine. During a routine physical 14 Nov 2003 (1 month post 3rd AVA vac), a CBC identified "mild microcytic anemia" (WBC 5.2 (nl), High 12; HCT 37 MCV 85; neut 47%; lymph 47%) otherwise normal). She admitted to being tired and a family history of hypothyroidism otherwise no complaints documented or remembered. Providers suggested diagnosis of "high probability thalassemia". On 20 June 2004 ( months post vaccination) she complain of 2 day hx of itchy scalp with tender scalp and hair loss (hx of similar hair loss at age 9-10), headaches (hx tension ha), increased fatigue, and cervical-aural lymphadenopathy. She was diagnosed with superficial cellulitis and given KEFLEX. F/u eval 6/28/04 dx tinea capitis (positive woods lamp) and given griseofulvin and selenium sulfide shampoo. By 7/3/04 her symptoms had not changed and she now reported fever of 102 F with night sweats. She was treated with ROCEPHIN 1 gm IM X 3 days. By 7/9/04 the lymphadenopathy was resolving; however she exhibited a new vesicular papular itchy rash to bilateral arms, face and oral thrush with a sore throat-diagnosed with possible allergic reaction to griseofulvin. Meds were stopped and she was treated with 7 day taper of Prednisone and given DIFLUCAN with resolution of symptoms except alopecia. While hair regrowth did occur, new sites would develop, dermatology referral:  2 punch biopsies showed "inflammatory scarring alopecia with features consistent with lupus erythematosus. Negative GMS fungal stain". She was diagnosed with discoid lupus 18 August 2004 and referred to internal medicine doe SLE. October 2004 (12 months post AVA#3 vac) repetitive monthly flare ups of alopecia, fevers, arthralgia was associated with onset of menstrual cycles. She was admitted by rheumatology October 6-12, 2004 with neutropenic fever (ANC 325 and c/o 2 week hx fevers>102F, chills, HA, fatigue, sore throat, mouth ulcers, arthralgia, chronic LBP). Symptoms resolved with supportive therapy. Features were noted to be suggestive of SLE or DLE converting to SLE with negative ANA, cytopenia, fever, adenopathy, arthralgia, and fatigue (see below labs). Rheumatology diagnosed ANA-negative SLE based on DLE lesions and organ symptomatology (cytopenia from 2004 to present day, she continues to be followed by rheumatology, PCP, dermatology, GYN, et at for re-flare of symptoms.  Follow-up - Patient's last name updated.
Age: 35.0
Sex: M
Vaccine: SMALL
Symptoms: Echocardiogram normal, Electrophoresis protein normal, Eosinophil percentage increased, Epstein-Barr virus antibody negative, Epstein-Barr virus antibody positive
Clinical narrative: This 41 year old female reported receipt of her primary DRYVAX on 25 June 2003. Three AVA vaccinations were administered on 06 Sept 2003, 22 Sept 2003, and 11 Oct 2003 with no remembered adverse events to either vaccine. During a routine physical 14 Nov 2003 (1 month post 3rd AVA vac), a CBC identified "mild microcytic anemia" (WBC 5.2 (nl), High 12; HCT 37 MCV 85; neut 47%; lymph 47%) otherwise normal). She admitted to being tired and a family history of hypothyroidism otherwise no complaints documented or remembered. Providers suggested diagnosis of "high probability thalassemia". On 20 June 2004 ( months post vaccination) she complain of 2 day hx of itchy scalp with tender scalp and hair loss (hx of similar hair loss at age 9-10), headaches (hx tension ha), increased fatigue, and cervical-aural lymphadenopathy. She was diagnosed with superficial cellulitis and given KEFLEX. F/u eval 6/28/04 dx tinea capitis (positive woods lamp) and given griseofulvin and selenium sulfide shampoo. By 7/3/04 her symptoms had not changed and she now reported fever of 102 F with night sweats. She was treated with ROCEPHIN 1 gm IM X 3 days. By 7/9/04 the lymphadenopathy was resolving; however she exhibited a new vesicular papular itchy rash to bilateral arms, face and oral thrush with a sore throat-diagnosed with possible allergic reaction to griseofulvin. Meds were stopped and she was treated with 7 day taper of Prednisone and given DIFLUCAN with resolution of symptoms except alopecia. While hair regrowth did occur, new sites would develop, dermatology referral:  2 punch biopsies showed "inflammatory scarring alopecia with features consistent with lupus erythematosus. Negative GMS fungal stain". She was diagnosed with discoid lupus 18 August 2004 and referred to internal medicine doe SLE. October 2004 (12 months post AVA#3 vac) repetitive monthly flare ups of alopecia, fevers, arthralgia was associated with onset of menstrual cycles. She was admitted by rheumatology October 6-12, 2004 with neutropenic fever (ANC 325 and c/o 2 week hx fevers>102F, chills, HA, fatigue, sore throat, mouth ulcers, arthralgia, chronic LBP). Symptoms resolved with supportive therapy. Features were noted to be suggestive of SLE or DLE converting to SLE with negative ANA, cytopenia, fever, adenopathy, arthralgia, and fatigue (see below labs). Rheumatology diagnosed ANA-negative SLE based on DLE lesions and organ symptomatology (cytopenia from 2004 to present day, she continues to be followed by rheumatology, PCP, dermatology, GYN, et at for re-flare of symptoms.  Follow-up - Patient's last name updated.
Age: 35.0
Sex: M
Vaccine: SMALL
Symptoms: Fatigue, Haematocrit decreased, Haemoglobin decreased, Haemoglobin normal, Headache
Clinical narrative: This 41 year old female reported receipt of her primary DRYVAX on 25 June 2003. Three AVA vaccinations were administered on 06 Sept 2003, 22 Sept 2003, and 11 Oct 2003 with no remembered adverse events to either vaccine. During a routine physical 14 Nov 2003 (1 month post 3rd AVA vac), a CBC identified "mild microcytic anemia" (WBC 5.2 (nl), High 12; HCT 37 MCV 85; neut 47%; lymph 47%) otherwise normal). She admitted to being tired and a family history of hypothyroidism otherwise no complaints documented or remembered. Providers suggested diagnosis of "high probability thalassemia". On 20 June 2004 ( months post vaccination) she complain of 2 day hx of itchy scalp with tender scalp and hair loss (hx of similar hair loss at age 9-10), headaches (hx tension ha), increased fatigue, and cervical-aural lymphadenopathy. She was diagnosed with superficial cellulitis and given KEFLEX. F/u eval 6/28/04 dx tinea capitis (positive woods lamp) and given griseofulvin and selenium sulfide shampoo. By 7/3/04 her symptoms had not changed and she now reported fever of 102 F with night sweats. She was treated with ROCEPHIN 1 gm IM X 3 days. By 7/9/04 the lymphadenopathy was resolving; however she exhibited a new vesicular papular itchy rash to bilateral arms, face and oral thrush with a sore throat-diagnosed with possible allergic reaction to griseofulvin. Meds were stopped and she was treated with 7 day taper of Prednisone and given DIFLUCAN with resolution of symptoms except alopecia. While hair regrowth did occur, new sites would develop, dermatology referral:  2 punch biopsies showed "inflammatory scarring alopecia with features consistent with lupus erythematosus. Negative GMS fungal stain". She was diagnosed with discoid lupus 18 August 2004 and referred to internal medicine doe SLE. October 2004 (12 months post AVA#3 vac) repetitive monthly flare ups of alopecia, fevers, arthralgia was associated with onset of menstrual cycles. She was admitted by rheumatology October 6-12, 2004 with neutropenic fever (ANC 325 and c/o 2 week hx fevers>102F, chills, HA, fatigue, sore throat, mouth ulcers, arthralgia, chronic LBP). Symptoms resolved with supportive therapy. Features were noted to be suggestive of SLE or DLE converting to SLE with negative ANA, cytopenia, fever, adenopathy, arthralgia, and fatigue (see below labs). Rheumatology diagnosed ANA-negative SLE based on DLE lesions and organ symptomatology (cytopenia from 2004 to present day, she continues to be followed by rheumatology, PCP, dermatology, GYN, et at for re-flare of symptoms.  Follow-up - Patient's last name updated.
Age: 35.0
Sex: M
Vaccine: SMALL
Symptoms: Laboratory test abnormal, Lymphadenopathy, Lymphocyte percentage increased, Mean cell volume normal, Microcytic anaemia
Clinical narrative: This 41 year old female reported receipt of her primary DRYVAX on 25 June 2003. Three AVA vaccinations were administered on 06 Sept 2003, 22 Sept 2003, and 11 Oct 2003 with no remembered adverse events to either vaccine. During a routine physical 14 Nov 2003 (1 month post 3rd AVA vac), a CBC identified "mild microcytic anemia" (WBC 5.2 (nl), High 12; HCT 37 MCV 85; neut 47%; lymph 47%) otherwise normal). She admitted to being tired and a family history of hypothyroidism otherwise no complaints documented or remembered. Providers suggested diagnosis of "high probability thalassemia". On 20 June 2004 ( months post vaccination) she complain of 2 day hx of itchy scalp with tender scalp and hair loss (hx of similar hair loss at age 9-10), headaches (hx tension ha), increased fatigue, and cervical-aural lymphadenopathy. She was diagnosed with superficial cellulitis and given KEFLEX. F/u eval 6/28/04 dx tinea capitis (positive woods lamp) and given griseofulvin and selenium sulfide shampoo. By 7/3/04 her symptoms had not changed and she now reported fever of 102 F with night sweats. She was treated with ROCEPHIN 1 gm IM X 3 days. By 7/9/04 the lymphadenopathy was resolving; however she exhibited a new vesicular papular itchy rash to bilateral arms, face and oral thrush with a sore throat-diagnosed with possible allergic reaction to griseofulvin. Meds were stopped and she was treated with 7 day taper of Prednisone and given DIFLUCAN with resolution of symptoms except alopecia. While hair regrowth did occur, new sites would develop, dermatology referral:  2 punch biopsies showed "inflammatory scarring alopecia with features consistent with lupus erythematosus. Negative GMS fungal stain". She was diagnosed with discoid lupus 18 August 2004 and referred to internal medicine doe SLE. October 2004 (12 months post AVA#3 vac) repetitive monthly flare ups of alopecia, fevers, arthralgia was associated with onset of menstrual cycles. She was admitted by rheumatology October 6-12, 2004 with neutropenic fever (ANC 325 and c/o 2 week hx fevers>102F, chills, HA, fatigue, sore throat, mouth ulcers, arthralgia, chronic LBP). Symptoms resolved with supportive therapy. Features were noted to be suggestive of SLE or DLE converting to SLE with negative ANA, cytopenia, fever, adenopathy, arthralgia, and fatigue (see below labs). Rheumatology diagnosed ANA-negative SLE based on DLE lesions and organ symptomatology (cytopenia from 2004 to present day, she continues to be followed by rheumatology, PCP, dermatology, GYN, et at for re-flare of symptoms.  Follow-up - Patient's last name updated.
Age: 35.0
Sex: M
Vaccine: SMALL
Symptoms: Monocyte count increased, Mouth ulceration, Neutrophil percentage decreased, Night sweats, Oral candidiasis
Clinical narrative: This 41 year old female reported receipt of her primary DRYVAX on 25 June 2003. Three AVA vaccinations were administered on 06 Sept 2003, 22 Sept 2003, and 11 Oct 2003 with no remembered adverse events to either vaccine. During a routine physical 14 Nov 2003 (1 month post 3rd AVA vac), a CBC identified "mild microcytic anemia" (WBC 5.2 (nl), High 12; HCT 37 MCV 85; neut 47%; lymph 47%) otherwise normal). She admitted to being tired and a family history of hypothyroidism otherwise no complaints documented or remembered. Providers suggested diagnosis of "high probability thalassemia". On 20 June 2004 ( months post vaccination) she complain of 2 day hx of itchy scalp with tender scalp and hair loss (hx of similar hair loss at age 9-10), headaches (hx tension ha), increased fatigue, and cervical-aural lymphadenopathy. She was diagnosed with superficial cellulitis and given KEFLEX. F/u eval 6/28/04 dx tinea capitis (positive woods lamp) and given griseofulvin and selenium sulfide shampoo. By 7/3/04 her symptoms had not changed and she now reported fever of 102 F with night sweats. She was treated with ROCEPHIN 1 gm IM X 3 days. By 7/9/04 the lymphadenopathy was resolving; however she exhibited a new vesicular papular itchy rash to bilateral arms, face and oral thrush with a sore throat-diagnosed with possible allergic reaction to griseofulvin. Meds were stopped and she was treated with 7 day taper of Prednisone and given DIFLUCAN with resolution of symptoms except alopecia. While hair regrowth did occur, new sites would develop, dermatology referral:  2 punch biopsies showed "inflammatory scarring alopecia with features consistent with lupus erythematosus. Negative GMS fungal stain". She was diagnosed with discoid lupus 18 August 2004 and referred to internal medicine doe SLE. October 2004 (12 months post AVA#3 vac) repetitive monthly flare ups of alopecia, fevers, arthralgia was associated with onset of menstrual cycles. She was admitted by rheumatology October 6-12, 2004 with neutropenic fever (ANC 325 and c/o 2 week hx fevers>102F, chills, HA, fatigue, sore throat, mouth ulcers, arthralgia, chronic LBP). Symptoms resolved with supportive therapy. Features were noted to be suggestive of SLE or DLE converting to SLE with negative ANA, cytopenia, fever, adenopathy, arthralgia, and fatigue (see below labs). Rheumatology diagnosed ANA-negative SLE based on DLE lesions and organ symptomatology (cytopenia from 2004 to present day, she continues to be followed by rheumatology, PCP, dermatology, GYN, et at for re-flare of symptoms.  Follow-up - Patient's last name updated.
Age: 35.0
Sex: M
Vaccine: SMALL
Symptoms: Oropharyngeal pain, Pancytopenia, Parvovirus B19 test negative, Pruritus, Pyrexia
Clinical narrative: This 41 year old female reported receipt of her primary DRYVAX on 25 June 2003. Three AVA vaccinations were administered on 06 Sept 2003, 22 Sept 2003, and 11 Oct 2003 with no remembered adverse events to either vaccine. During a routine physical 14 Nov 2003 (1 month post 3rd AVA vac), a CBC identified "mild microcytic anemia" (WBC 5.2 (nl), High 12; HCT 37 MCV 85; neut 47%; lymph 47%) otherwise normal). She admitted to being tired and a family history of hypothyroidism otherwise no complaints documented or remembered. Providers suggested diagnosis of "high probability thalassemia". On 20 June 2004 ( months post vaccination) she complain of 2 day hx of itchy scalp with tender scalp and hair loss (hx of similar hair loss at age 9-10), headaches (hx tension ha), increased fatigue, and cervical-aural lymphadenopathy. She was diagnosed with superficial cellulitis and given KEFLEX. F/u eval 6/28/04 dx tinea capitis (positive woods lamp) and given griseofulvin and selenium sulfide shampoo. By 7/3/04 her symptoms had not changed and she now reported fever of 102 F with night sweats. She was treated with ROCEPHIN 1 gm IM X 3 days. By 7/9/04 the lymphadenopathy was resolving; however she exhibited a new vesicular papular itchy rash to bilateral arms, face and oral thrush with a sore throat-diagnosed with possible allergic reaction to griseofulvin. Meds were stopped and she was treated with 7 day taper of Prednisone and given DIFLUCAN with resolution of symptoms except alopecia. While hair regrowth did occur, new sites would develop, dermatology referral:  2 punch biopsies showed "inflammatory scarring alopecia with features consistent with lupus erythematosus. Negative GMS fungal stain". She was diagnosed with discoid lupus 18 August 2004 and referred to internal medicine doe SLE. October 2004 (12 months post AVA#3 vac) repetitive monthly flare ups of alopecia, fevers, arthralgia was associated with onset of menstrual cycles. She was admitted by rheumatology October 6-12, 2004 with neutropenic fever (ANC 325 and c/o 2 week hx fevers>102F, chills, HA, fatigue, sore throat, mouth ulcers, arthralgia, chronic LBP). Symptoms resolved with supportive therapy. Features were noted to be suggestive of SLE or DLE converting to SLE with negative ANA, cytopenia, fever, adenopathy, arthralgia, and fatigue (see below labs). Rheumatology diagnosed ANA-negative SLE based on DLE lesions and organ symptomatology (cytopenia from 2004 to present day, she continues to be followed by rheumatology, PCP, dermatology, GYN, et at for re-flare of symptoms.  Follow-up - Patient's last name updated.
Age: 35.0
Sex: M
Vaccine: SMALL
Symptoms: Rash papular, Rash pruritic, Red blood cell count decreased, Red blood cell sedimentation rate increased, Serum ferritin normal
Clinical narrative: This 41 year old female reported receipt of her primary DRYVAX on 25 June 2003. Three AVA vaccinations were administered on 06 Sept 2003, 22 Sept 2003, and 11 Oct 2003 with no remembered adverse events to either vaccine. During a routine physical 14 Nov 2003 (1 month post 3rd AVA vac), a CBC identified "mild microcytic anemia" (WBC 5.2 (nl), High 12; HCT 37 MCV 85; neut 47%; lymph 47%) otherwise normal). She admitted to being tired and a family history of hypothyroidism otherwise no complaints documented or remembered. Providers suggested diagnosis of "high probability thalassemia". On 20 June 2004 ( months post vaccination) she complain of 2 day hx of itchy scalp with tender scalp and hair loss (hx of similar hair loss at age 9-10), headaches (hx tension ha), increased fatigue, and cervical-aural lymphadenopathy. She was diagnosed with superficial cellulitis and given KEFLEX. F/u eval 6/28/04 dx tinea capitis (positive woods lamp) and given griseofulvin and selenium sulfide shampoo. By 7/3/04 her symptoms had not changed and she now reported fever of 102 F with night sweats. She was treated with ROCEPHIN 1 gm IM X 3 days. By 7/9/04 the lymphadenopathy was resolving; however she exhibited a new vesicular papular itchy rash to bilateral arms, face and oral thrush with a sore throat-diagnosed with possible allergic reaction to griseofulvin. Meds were stopped and she was treated with 7 day taper of Prednisone and given DIFLUCAN with resolution of symptoms except alopecia. While hair regrowth did occur, new sites would develop, dermatology referral:  2 punch biopsies showed "inflammatory scarring alopecia with features consistent with lupus erythematosus. Negative GMS fungal stain". She was diagnosed with discoid lupus 18 August 2004 and referred to internal medicine doe SLE. October 2004 (12 months post AVA#3 vac) repetitive monthly flare ups of alopecia, fevers, arthralgia was associated with onset of menstrual cycles. She was admitted by rheumatology October 6-12, 2004 with neutropenic fever (ANC 325 and c/o 2 week hx fevers>102F, chills, HA, fatigue, sore throat, mouth ulcers, arthralgia, chronic LBP). Symptoms resolved with supportive therapy. Features were noted to be suggestive of SLE or DLE converting to SLE with negative ANA, cytopenia, fever, adenopathy, arthralgia, and fatigue (see below labs). Rheumatology diagnosed ANA-negative SLE based on DLE lesions and organ symptomatology (cytopenia from 2004 to present day, she continues to be followed by rheumatology, PCP, dermatology, GYN, et at for re-flare of symptoms.  Follow-up - Patient's last name updated.
Age: 35.0
Sex: M
Vaccine: SMALL
Symptoms: Systemic lupus erythematosus, Tenderness, Thalassaemia, Tinea capitis, Toxoplasma serology positive
Clinical narrative: This 41 year old female reported receipt of her primary DRYVAX on 25 June 2003. Three AVA vaccinations were administered on 06 Sept 2003, 22 Sept 2003, and 11 Oct 2003 with no remembered adverse events to either vaccine. During a routine physical 14 Nov 2003 (1 month post 3rd AVA vac), a CBC identified "mild microcytic anemia" (WBC 5.2 (nl), High 12; HCT 37 MCV 85; neut 47%; lymph 47%) otherwise normal). She admitted to being tired and a family history of hypothyroidism otherwise no complaints documented or remembered. Providers suggested diagnosis of "high probability thalassemia". On 20 June 2004 ( months post vaccination) she complain of 2 day hx of itchy scalp with tender scalp and hair loss (hx of similar hair loss at age 9-10), headaches (hx tension ha), increased fatigue, and cervical-aural lymphadenopathy. She was diagnosed with superficial cellulitis and given KEFLEX. F/u eval 6/28/04 dx tinea capitis (positive woods lamp) and given griseofulvin and selenium sulfide shampoo. By 7/3/04 her symptoms had not changed and she now reported fever of 102 F with night sweats. She was treated with ROCEPHIN 1 gm IM X 3 days. By 7/9/04 the lymphadenopathy was resolving; however she exhibited a new vesicular papular itchy rash to bilateral arms, face and oral thrush with a sore throat-diagnosed with possible allergic reaction to griseofulvin. Meds were stopped and she was treated with 7 day taper of Prednisone and given DIFLUCAN with resolution of symptoms except alopecia. While hair regrowth did occur, new sites would develop, dermatology referral:  2 punch biopsies showed "inflammatory scarring alopecia with features consistent with lupus erythematosus. Negative GMS fungal stain". She was diagnosed with discoid lupus 18 August 2004 and referred to internal medicine doe SLE. October 2004 (12 months post AVA#3 vac) repetitive monthly flare ups of alopecia, fevers, arthralgia was associated with onset of menstrual cycles. She was admitted by rheumatology October 6-12, 2004 with neutropenic fever (ANC 325 and c/o 2 week hx fevers>102F, chills, HA, fatigue, sore throat, mouth ulcers, arthralgia, chronic LBP). Symptoms resolved with supportive therapy. Features were noted to be suggestive of SLE or DLE converting to SLE with negative ANA, cytopenia, fever, adenopathy, arthralgia, and fatigue (see below labs). Rheumatology diagnosed ANA-negative SLE based on DLE lesions and organ symptomatology (cytopenia from 2004 to present day, she continues to be followed by rheumatology, PCP, dermatology, GYN, et at for re-flare of symptoms.  Follow-up - Patient's last name updated.
Age: 35.0
Sex: M
Vaccine: SMALL
Symptoms: Transferrin normal, Tuberculin test positive, Urine analysis normal, White blood cell count decreased
Clinical narrative: This 41 year old female reported receipt of her primary DRYVAX on 25 June 2003. Three AVA vaccinations were administered on 06 Sept 2003, 22 Sept 2003, and 11 Oct 2003 with no remembered adverse events to either vaccine. During a routine physical 14 Nov 2003 (1 month post 3rd AVA vac), a CBC identified "mild microcytic anemia" (WBC 5.2 (nl), High 12; HCT 37 MCV 85; neut 47%; lymph 47%) otherwise normal). She admitted to being tired and a family history of hypothyroidism otherwise no complaints documented or remembered. Providers suggested diagnosis of "high probability thalassemia". On 20 June 2004 ( months post vaccination) she complain of 2 day hx of itchy scalp with tender scalp and hair loss (hx of similar hair loss at age 9-10), headaches (hx tension ha), increased fatigue, and cervical-aural lymphadenopathy. She was diagnosed with superficial cellulitis and given KEFLEX. F/u eval 6/28/04 dx tinea capitis (positive woods lamp) and given griseofulvin and selenium sulfide shampoo. By 7/3/04 her symptoms had not changed and she now reported fever of 102 F with night sweats. She was treated with ROCEPHIN 1 gm IM X 3 days. By 7/9/04 the lymphadenopathy was resolving; however she exhibited a new vesicular papular itchy rash to bilateral arms, face and oral thrush with a sore throat-diagnosed with possible allergic reaction to griseofulvin. Meds were stopped and she was treated with 7 day taper of Prednisone and given DIFLUCAN with resolution of symptoms except alopecia. While hair regrowth did occur, new sites would develop, dermatology referral:  2 punch biopsies showed "inflammatory scarring alopecia with features consistent with lupus erythematosus. Negative GMS fungal stain". She was diagnosed with discoid lupus 18 August 2004 and referred to internal medicine doe SLE. October 2004 (12 months post AVA#3 vac) repetitive monthly flare ups of alopecia, fevers, arthralgia was associated with onset of menstrual cycles. She was admitted by rheumatology October 6-12, 2004 with neutropenic fever (ANC 325 and c/o 2 week hx fevers>102F, chills, HA, fatigue, sore throat, mouth ulcers, arthralgia, chronic LBP). Symptoms resolved with supportive therapy. Features were noted to be suggestive of SLE or DLE converting to SLE with negative ANA, cytopenia, fever, adenopathy, arthralgia, and fatigue (see below labs). Rheumatology diagnosed ANA-negative SLE based on DLE lesions and organ symptomatology (cytopenia from 2004 to present day, she continues to be followed by rheumatology, PCP, dermatology, GYN, et at for re-flare of symptoms.  Follow-up - Patient's last name updated.
Age: 8.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Urticaria
Clinical narrative: Patient keeps breaking out in Hives on and off. Allergy Meds were given and didn't treat condition. so Doctor appt. was made.
Age: 1.1
Sex: M
Vaccine: HIBV, MMRV, PNC
Symptoms: Asthenia, Ataxia, Motor dysfunction, Neurological symptom, Nystagmus
Clinical narrative: Pt. developed neurologic symptoms, including weakness, ataxia, loss of motor skill and verbal skills, nystagmus. Diagnosed w/ Opsoclonus myoclonus syndrome.
Age: 1.1
Sex: M
Vaccine: HIBV, MMRV, PNC
Symptoms: Opsoclonus myoclonus, Speech disorder
Clinical narrative: Pt. developed neurologic symptoms, including weakness, ataxia, loss of motor skill and verbal skills, nystagmus. Diagnosed w/ Opsoclonus myoclonus syndrome.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, FLU3, PNC13
Symptoms: Apnoea, Aspiration, Condition aggravated, Death, Lissencephaly
Clinical narrative: Patient had life threatening lissencephaly aspiration (G Butter Fed) & mixed apnea known risk & partial no code.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Cyanosis, Hypotonia, Retching, Unresponsive to stimuli, Vomiting
Clinical narrative: 4/7/10 Emesis x 3-4. Then wretching and became blue and limp. Pulse Ox 84%. 911 called. Baby very unresponsive and gradually became more alert. No definitive seizure activity.
Age: 20.0
Sex: F
Vaccine: HPV4, MEN
Symptoms: Abdominal discomfort, Feeling hot, Headache, Pyrexia
Clinical narrative: Received 2 immunizations at about 1045 4/9/10 - at about 1900 stomach upset, headache, fever 100 degrees. Feels hot all over. Reported this reaction 4/12/2010 with continued symptoms. No numbness or tingling.
Age: 46.0
Sex: M
Vaccine: FLU(H1N1), TDAP
Symptoms: Hypoaesthesia, Pain in extremity
Clinical narrative: 6 days after receiving vaccine member experienced pain and numbness in left arm. Now just occasional pain and no more numbness.
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Full blood count, Injection site erythema, Injection site nodule, Injection site warmth
Clinical narrative: Pt states injection site felt like a knot. Since injection on 4/13/10, the area surrounding site has become erythemic/hot to touch and possible 2 degree infection. Erythema extended from top of deltoid to antecubital area.
Age: 2.0
Sex: F
Vaccine: DTAP, HIBV, MMR
Symptoms: Rash erythematous, Rash maculo-papular
Clinical narrative: Pt had rash develop approx. 10 days after MMR immunization. She had maculopapular red rash on trunk and face and arms. Symptomatic treatment was done.
Age: 35.0
Sex: F
Vaccine: MMR
Symptoms: Injection site erythema, Injection site pruritus, Injection site reaction, Injection site warmth
Clinical narrative: States adverse event started approximately equal to 24 hours after receiving vaccine. Localized reaction at site of injection. Presently has a reddened circular area approximately equal to 2" diameter - area warm to touch and she comp. of the site being itchy. States she took BENADRYL with little to no effect. Now on ABX. from PCP.
Age: 36.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Immunisation reaction, Rash
Clinical narrative: Rash on both arms and legs, tops of feet up to inner thigh. Patient saw dermatologist and due to the symmetry of the rash the physician believed it was from the injection. Patient was given a steriod cream and also a steroid injection.
Age: 11.0
Sex: M
Vaccine: TDAP
Symptoms: Cold sweat, Syncope, Unresponsive to stimuli
Clinical narrative: 11 y.o. in with grandma for Tdap and had severe Syncopal episode minutes later. Unresponsive briefly and clammy T994 P72 R20 BP 94/64- EMS called and pt. taken to Hospital- Discharged with eval and returned to school following day.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Gait disturbance, Hyperaesthesia, Muscular weakness, Pyrexia
Clinical narrative: fever, sensitivity to light touch, weakness of arms and legs, unstable walking
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Lt arm, swelling on injection site, redness and warmth.
Age: 0.18
Sex: F
Vaccine: DTPIHI, PPV, RVX
Symptoms: Haematochezia, Mucous stools
Clinical narrative: After the vaccination my child started having large mucusy stools with small amounts of bright red blood in them. She would have 1 or 2 mucusy stools and then a couple normal ones for the first week. The second week the stools became more frequent. She is having at least 1 a day now and it has been going on for 2-3 weeks. She did not have any of these bloody or mucusy stools prior to her vaccination.
Age: 25.0
Sex: F
Vaccine: HEPAB
Symptoms: Rash erythematous
Clinical narrative: Patient stated on Jan 16, 2010, she noticed while at home a few small red bumps on side of left arm close to body, between wrist and elbow. She stated on Jan. 19, 2010 she noticed more bumps on her chest and back area. She went to ER at hosp. Doctor gave her BENADRYL and a "steroid" to take. She doesn't remember name of steroid. The doctor gave her a referral to an allergist to determine if bumps were a reaction to vaccine. She already made an appt. to go in March 2010.
Age: 43.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Abdominal discomfort, Blood glucose decreased, Blood pressure decreased, Feeling hot, Gait disturbance
Clinical narrative: Patient reported "feeling warm" "feeling funny in stomach" after receiving both varicella and MMR in separate limbs while, sitting in a chair. Patient stated feeling "somewhat better, not 100%". He began exit to check out Nurse suggest he wait longer in another room / while walking to other room to rest, patient gait became unsteady. And was escorted to a chair 911 was called. While waiting for EMT B/P 90/60 skin cool Pulse 66. Patient still talking answering questions had a bowl rice three hours before. Before that meal was right before EMT arrived. Patient signed their paper to refuse to leave with EMT.
Age: 1.02
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Herpes zoster
Clinical narrative: Diagnosed with shingles 4/14/2010 - Vaccinated with VARIVAX 9-9-2008.
Age: 63.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Injection site erythema, Injection site warmth, Local reaction
Clinical narrative: Localized redness and warmth at site.
Age: 30.0
Sex: F
Vaccine: HEPAB, MMR, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Redness to RT upper arm, slightly raised and warm to touch, c/o soreness area of redness is where varicella vaccine was given . Advised warm compresses, to seek med. care if continue to swell.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Headache, Injection site pain, Nausea, Pyrexia, Streptococcus test
Clinical narrative: Pt developed fever 104.8, nausea, headache, soreness at inj. site. Given MOTRIN - temp 102 degrees in office 4-15-10 815am checked - strep (-) - Pt will tx with TYLENOL/MOTRIN.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Streptococcus test negative
Clinical narrative: Pt developed fever 104.8, nausea, headache, soreness at inj. site. Given MOTRIN - temp 102 degrees in office 4-15-10 815am checked - strep (-) - Pt will tx with TYLENOL/MOTRIN.
Age: 44.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Upper respiratory tract congestion
Clinical narrative: client c/o redness,swelling over back of rt. arm where varicella was adm. (4/12);symptoms first noticed by client 4/13/10;RN observed area of erythema and thickness of about 3 x 6 in. on back of rt. arm; some heat to touch noticed;client took Claritin D 4/13 pm due to "congestion"; reports swelling much worse initially but much improved upon report being made on 4/15/10
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Convulsion, Full blood count, Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Softball size swelling and redness at site of shot, developed fever of 105 in a half hour leading into a 20 min convulsion
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Urine analysis, White blood cell count increased
Clinical narrative: Softball size swelling and redness at site of shot, developed fever of 105 in a half hour leading into a 20 min convulsion
Age: 0.18
Sex: M
Vaccine: RV1
Symptoms: Incorrect route of drug administration
Clinical narrative: Rotarix an oral vaccine was administered as IM shot
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Erythema, Skin warm
Clinical narrative: (L) thigh large cup sized red heated spot. Resolved within 72 hours.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Flushing, Hypersensitivity, Hypertension, Pain
Clinical narrative: Pt was given ZOSTAVAX, 10 minutes after receiving vaccine in left arm pt c/o terrible itching.  Left side of chest 5 inch area of redness noted on left side spreading to her back.  No redness or itching at injection site pt c/o feeling flushed.  BP 170/102, AP 84 reg.  Denies any difficult tx breathing.  Telephone call to PCP who ordered BENADRYL 25 mg two tabs now.  Pt took BENADRYL at 4:35 PM.  Ice pack applied to red, itching area left side of chest (under arm) 4:45 PM.  BP 150/98, AP 84 regular.  Rash continues to spread, pt c/o itching.  Pt denies difficulty breathing.  Pt was instructed she needed to go to local emergency room for evaluation.  Pt request RN call her PCP (primary care physician) pt does not want to go to ER due to the cost.  4:50 PM telephone call to PCP spoke with office nurse, PCP has left the office, no other provider is in the office.  Pt is agreeable to go to emergency room.  She refuses transport via ambulance, pt is willing to have her husband drive her.  5 PM BP 152/98, AP 84 reg.  Pt denies any difficulty breathing, continues to c/o itching under left arm redness continues.  Pt. to ER informed pt RN will call her tomorrow:  5 PM telephone call to hospital ER spoke with nurse informed pt coming to ER & given history.  5:30 PM husband called to confirm they were in ER - RN.  3/31/2010 8 AM telephone call to pt. RN asking how she was doing?  Pt states she has no itching or redness left lateral side of chest has scratch marks & soreness from itching.  Pt denied having any difficulty breathing and no redness or itching at injection site.  Pt was given PREDNISONE in the ER & was sent home on PREDNISONE 20 mg 3 tabs a day X 4 days by mouth.  Continue BENADRYL if needed. - RN.  3/31/2010 telephone call to Hosp..... spoke with infection control manager who confirmed treatment plan.  Diagnosis rash, itching no difficulty breathing after receiving ZOSTAVAX - Allergic reaction - RN.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Rash
Clinical narrative: Pt was given ZOSTAVAX, 10 minutes after receiving vaccine in left arm pt c/o terrible itching.  Left side of chest 5 inch area of redness noted on left side spreading to her back.  No redness or itching at injection site pt c/o feeling flushed.  BP 170/102, AP 84 reg.  Denies any difficult tx breathing.  Telephone call to PCP who ordered BENADRYL 25 mg two tabs now.  Pt took BENADRYL at 4:35 PM.  Ice pack applied to red, itching area left side of chest (under arm) 4:45 PM.  BP 150/98, AP 84 regular.  Rash continues to spread, pt c/o itching.  Pt denies difficulty breathing.  Pt was instructed she needed to go to local emergency room for evaluation.  Pt request RN call her PCP (primary care physician) pt does not want to go to ER due to the cost.  4:50 PM telephone call to PCP spoke with office nurse, PCP has left the office, no other provider is in the office.  Pt is agreeable to go to emergency room.  She refuses transport via ambulance, pt is willing to have her husband drive her.  5 PM BP 152/98, AP 84 reg.  Pt denies any difficulty breathing, continues to c/o itching under left arm redness continues.  Pt. to ER informed pt RN will call her tomorrow:  5 PM telephone call to hospital ER spoke with nurse informed pt coming to ER & given history.  5:30 PM husband called to confirm they were in ER - RN.  3/31/2010 8 AM telephone call to pt. RN asking how she was doing?  Pt states she has no itching or redness left lateral side of chest has scratch marks & soreness from itching.  Pt denied having any difficulty breathing and no redness or itching at injection site.  Pt was given PREDNISONE in the ER & was sent home on PREDNISONE 20 mg 3 tabs a day X 4 days by mouth.  Continue BENADRYL if needed. - RN.  3/31/2010 telephone call to Hosp..... spoke with infection control manager who confirmed treatment plan.  Diagnosis rash, itching no difficulty breathing after receiving ZOSTAVAX - Allergic reaction - RN.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Abdominal pain upper, Cough, Injection site erythema, Pyrexia, Rash
Clinical narrative: Child at 11 months old would get stomach pain, vomiting & rash.  Pediatric allergist diagnosed egg & peanut allergies.  No one else in family has these allergies.  Mother has tired to eliminate all eggs from diet since 5/2006.  Child awakened 4-14-10 12 hrs after shots with wheezing, cough, vomiting and fever.  Redness on right upper arm.  Mother called to see if vaccine insert warned of egg protein allergies.  Insert read to mother.  Mother did not notify nurses of egg & peanut allergies prior to shots given.  VIS no longer lists egg allergy as a caution.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Vomiting, Wheezing
Clinical narrative: Child at 11 months old would get stomach pain, vomiting & rash.  Pediatric allergist diagnosed egg & peanut allergies.  No one else in family has these allergies.  Mother has tired to eliminate all eggs from diet since 5/2006.  Child awakened 4-14-10 12 hrs after shots with wheezing, cough, vomiting and fever.  Redness on right upper arm.  Mother called to see if vaccine insert warned of egg protein allergies.  Insert read to mother.  Mother did not notify nurses of egg & peanut allergies prior to shots given.  VIS no longer lists egg allergy as a caution.
Age: 36.0
Sex: F
Vaccine: FLU3, FLU(H1N1)
Symptoms: Blood test, Burning sensation, Discomfort, Hypoaesthesia, Injection site pain
Clinical narrative: Burning pain at injection site spread to entire arm; 2.5 weeks later (~10/26/2009), developed bilateral lower leg paresthesia. Initially, symptoms included tingling, then numbness, followed by burning. Symptoms developed over a month and have been present daily since. Symptoms are sensory (never lost reflexes), in lower legs, very uncomfortable. Arm is better, but continues to hurt. Treatment: Neurontin.
Age: 36.0
Sex: F
Vaccine: FLU3, FLU(H1N1)
Symptoms: Nuclear magnetic resonance imaging, Pain, Paraesthesia, Sensory disturbance
Clinical narrative: Burning pain at injection site spread to entire arm; 2.5 weeks later (~10/26/2009), developed bilateral lower leg paresthesia. Initially, symptoms included tingling, then numbness, followed by burning. Symptoms developed over a month and have been present daily since. Symptoms are sensory (never lost reflexes), in lower legs, very uncomfortable. Arm is better, but continues to hurt. Treatment: Neurontin.
Age: 36.0
Sex: F
Vaccine: FLU3, FLU(H1N1)
Symptoms: Burning sensation, Ear pain, Influenza like illness, Laboratory test normal, Pain in extremity
Clinical narrative: Burning pain at injection site spread to entire arm; 2.5 weeks later (~10/26/2009), developed bilateral lower leg paresthesia. Initially, symptoms included tingling, then numbness, followed by burning. Symptoms developed over a month and have been present daily since. Symptoms are sensory (never lost reflexes), in lower legs, very uncomfortable. Arm is better, but continues to hurt. Treatment: Neurontin.
Age: 36.0
Sex: F
Vaccine: FLU3, FLU(H1N1)
Symptoms: Paraesthesia
Clinical narrative: Burning pain at injection site spread to entire arm; 2.5 weeks later (~10/26/2009), developed bilateral lower leg paresthesia. Initially, symptoms included tingling, then numbness, followed by burning. Symptoms developed over a month and have been present daily since. Symptoms are sensory (never lost reflexes), in lower legs, very uncomfortable. Arm is better, but continues to hurt. Treatment: Neurontin.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Dizziness, Hallucination, Headache, Pyrexia
Clinical narrative: fever 105  dizzy Headache  Hallucinations
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site urticaria
Clinical narrative: 4 days after injection of 4 yr. vaccines (DTaP, IPV, MMR, Varicella) patient with urticarial response starting on left leg.
Age: 1.24
Sex: M
Vaccine: HIBV, IPV, MMR
Symptoms: Rash
Clinical narrative: Rash 7 days after MMR given.
Age: 1.25
Sex: M
Vaccine: HIBV, MMR, PNC
Symptoms: Pyrexia
Clinical narrative: Fever 101 degrees F starting 4 13 10; 4 14 10 fever went up to 103 degrees F.
Age: 1.29
Sex: M
Vaccine: HIBV, MMR, PNC
Symptoms: Pyrexia, Rash
Clinical narrative: On 4 13 10 father called in regards to rash on forehead and upper trunk (had low grade fever 99.3 degrees F since day of vaccination).
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Pain, Skin warm
Clinical narrative: Area of redness x 5 1/2 ". Sore to touch. Heat from spot.
Sex: M
Vaccine: TYP
Symptoms: Abdominal pain, Arthralgia, Asthenia, Body temperature increased, Diarrhoea
Clinical narrative: 102.0 degrees temp. Muscle, skin, and joint aches. Nausea. Mild abdominal cramping and diarrhea. Felt weak.
Sex: M
Vaccine: TYP
Symptoms: Myalgia, Nausea, Pain of skin
Clinical narrative: 102.0 degrees temp. Muscle, skin, and joint aches. Nausea. Mild abdominal cramping and diarrhea. Felt weak.
Age: 39.0
Sex: F
Vaccine: HEP
Symptoms: Blood test, Dizziness, Headache, Injection site swelling, Nausea
Clinical narrative: Swelling at site, headaches, nausea. Swelling of face, dizziness. Tx @ local hospital. Given BENADRYL dip and THOREDOL and released.
Age: 39.0
Sex: F
Vaccine: HEP
Symptoms: Swelling face
Clinical narrative: Swelling at site, headaches, nausea. Swelling of face, dizziness. Tx @ local hospital. Given BENADRYL dip and THOREDOL and released.
Age: 1.3
Sex: M
Vaccine: HIBV, MMR, PNC
Symptoms: Pyrexia, Rash generalised
Clinical narrative: Broke out into rash on 1 27 08 all over body then had fever 103 degrees F increase on 1 28 08 for 2-3 days.
Age: 20.0
Sex: M
Vaccine: MMR
Symptoms: Rash pruritic
Clinical narrative: Rash which started 24 hrs later 7" diameter itchy, healed 24 hrs later. Rash was on abdomen only.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Administered DTAP/IPV/MMR/VARICELL left arm swollen red, painful.
Age: 22.0
Sex: M
Vaccine: TDAP, TYP
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Band neutrophil count decreased, Blood bilirubin normal, Chills
Clinical narrative: 4/9/10, 10:30 TDAP given 17:45 started to feel "not right". 18:00 took oral typhoid vaccine. Continued dizzy, didn't eat. 21:00 shaking chills, "feverish" 4/10/10 dizzy, hard to stand headache. 4/11/10 morning - urine discolored, eyes yellow. Afternoon, felt fine went to ED for labs. 4/11/10 fine except H/A.
Age: 22.0
Sex: M
Vaccine: TDAP, TYP
Symptoms: Chromaturia, Cytomegalovirus test negative, Dizziness, Dysstasia, Feeling abnormal
Clinical narrative: 4/9/10, 10:30 TDAP given 17:45 started to feel "not right". 18:00 took oral typhoid vaccine. Continued dizzy, didn't eat. 21:00 shaking chills, "feverish" 4/10/10 dizzy, hard to stand headache. 4/11/10 morning - urine discolored, eyes yellow. Afternoon, felt fine went to ED for labs. 4/11/10 fine except H/A.
Age: 22.0
Sex: M
Vaccine: TDAP, TYP
Symptoms: Feeling hot, Headache, Lymphocyte count normal, Monocyte count normal, Platelet count decreased
Clinical narrative: 4/9/10, 10:30 TDAP given 17:45 started to feel "not right". 18:00 took oral typhoid vaccine. Continued dizzy, didn't eat. 21:00 shaking chills, "feverish" 4/10/10 dizzy, hard to stand headache. 4/11/10 morning - urine discolored, eyes yellow. Afternoon, felt fine went to ED for labs. 4/11/10 fine except H/A.
Age: 22.0
Sex: M
Vaccine: TDAP, TYP
Symptoms: Scleral discolouration, Tremor, White blood cell count decreased
Clinical narrative: 4/9/10, 10:30 TDAP given 17:45 started to feel "not right". 18:00 took oral typhoid vaccine. Continued dizzy, didn't eat. 21:00 shaking chills, "feverish" 4/10/10 dizzy, hard to stand headache. 4/11/10 morning - urine discolored, eyes yellow. Afternoon, felt fine went to ED for labs. 4/11/10 fine except H/A.
Age: 0.52
Sex: M
Vaccine: DTAPIPVHIB, PNC
Symptoms: Death, Increased bronchial secretion, Skeletal survey
Clinical narrative: Patient asymptomatic on day of immunization. Afebrile before and after immunization. Patient found dead next day with face down on bed with lots of secretions.
Sex: F
Vaccine: HEPA
Symptoms: Caesarean section, Drug exposure during pregnancy, Neonatal disorder
Clinical narrative: This prospective pregnancy case was reported by a healthcare professional and described the occurrence of respiratory syncytial virus in a female neonate exposed to HAVRIX (GlaxoSmithKline) transplacentally when her mother was being treated. The neonate was also exposed to KALETRA, TRUVADA, Azithromycin, Valacyclovir, Metronidazole, VENTOLIN HFA, MEPRON, Albuterol, Ferrous sulfate, Prenatal vitamins and TERAZOL transplacentally which the mother took currently. On 03 August 2009, the 23-year-old mother of the neonate received the 1st dose of HAVRIX (unknown, unknown arm). The mother's last menstrual period was on an unspecified date and estimated date of delivery was on 20 January 2010. The neonate was exposed to HAVRIX during the 2nd trimester at 16 weeks. On 29 December 2009, at 36 weeks and six days gestation, the neonate was delivered by cesarean section; weight, Apgar score and length were not provided. On 13 January 2010, the neonate experienced respiratory syncytial virus and weight loss. At the time of reporting the outcome of the respiratory syncytial virus and weight loss was unspecified. The subject was hospitalised and the healthcare professional considered the events were clinically significant (or requiring intervention). Relevant test results included Respiratory syncytial virus (RSV) Antigen EIA, nasopharyngeal swab: positive on 13 January 2010. Please see A0801954A for details regarding the mother case.